USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	059436/0055			Pages:	61
		Recorded:	03/18/2022
Attorney Dkt #:	687747.0062
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 100
Page 1 of 2
Pages: 1 2

Patent #:	10293049	Issue Dt:	05/21/2019	Application #:	13654735	Filing Dt:	10/18/2012
Publication #:	US20130108632	Pub Dt:	05/02/2013
Title:	Etanercept Formulations Stabilized with Amino Acids

Patent #:	9801942	Issue Dt:	10/31/2017	Application #:	13654770	Filing Dt:	10/18/2012
Publication #:	US20130108633	Pub Dt:	05/02/2013
Title:	Etanercept Formulations Stabilized with Metal Ions

Patent #:	10493151	Issue Dt:	12/03/2019	Application #:	13654795	Filing Dt:	10/18/2012
Title:	Etanercept Formulations Stabilized with Sodium Chloride

Patent #:	10485869	Issue Dt:	11/26/2019	Application #:	13654903	Filing Dt:	10/18/2012
Title:	Etanercept Formulations Stabilized with Meglumine

Patent #:	9393305	Issue Dt:	07/19/2016	Application #:	13654919	Filing Dt:	10/18/2012
Publication #:	US20130101584	Pub Dt:	04/25/2013
Title:	Etanercept Formulations Stabilized with Xylitol

Patent #:	9302002	Issue Dt:	04/05/2016	Application #:	13654950	Filing Dt:	10/18/2012
Publication #:	US20130101640	Pub Dt:	04/25/2013
Title:	Etanercept Formulations Stabilized with Combinations of Sugars and Polyols

Patent #:	9675603	Issue Dt:	06/13/2017	Application #:	13824776	Filing Dt:	06/03/2013
Publication #:	US20130243865	Pub Dt:	09/19/2013
Title:	SOLID PHARMACEUTICAL COMPOSITIONS OF PPARY MODULATOR

Patent #:	9061020	Issue Dt:	06/23/2015	Application #:	14162723	Filing Dt:	01/23/2014
Publication #:	US20140213612	Pub Dt:	07/31/2014
Title:	PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

Patent #:	9765139	Issue Dt:	09/19/2017	Application #:	14226522	Filing Dt:	03/26/2014
Publication #:	US20140296489	Pub Dt:	10/02/2014
Title:	PERFUSION METHOD FOR MANUFACTURING ETANERCEPT

Patent #:	10822429	Issue Dt:	11/03/2020	Application #:	14592569	Filing Dt:	01/08/2015
Publication #:	US20150125532	Pub Dt:	05/07/2015
Title:	Etanercept Formulations Exhibiting Marked Reduction in Sub-Visible Particles

Patent #:	9662396	Issue Dt:	05/30/2017	Application #:	14592654	Filing Dt:	01/08/2015
Publication #:	US20150196645	Pub Dt:	07/16/2015
Title:	STABLE AQUEOUS FORMULATIONS OF ETANERCEPT

Patent #:	10047141	Issue Dt:	08/14/2018	Application #:	14609225	Filing Dt:	01/29/2015
Publication #:	US20150210750	Pub Dt:	07/30/2015
Title:	METHOD OF MANUFACTURING A PROTEIN BY PERFUSION IN MEDIA WITH A LOW AMINO ACID CONCENTRATION

Patent #:	9340611	Issue Dt:	05/17/2016	Application #:	14643844	Filing Dt:	03/10/2015
Publication #:	US20150182626	Pub Dt:	07/02/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9340612	Issue Dt:	05/17/2016	Application #:	14661288	Filing Dt:	03/18/2015
Publication #:	US20150190512	Pub Dt:	07/09/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9782479	Issue Dt:	10/10/2017	Application #:	14661849	Filing Dt:	03/18/2015
Publication #:	US20150190513	Pub Dt:	07/09/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9346880	Issue Dt:	05/24/2016	Application #:	14661899	Filing Dt:	03/18/2015
Publication #:	US20150191538	Pub Dt:	07/09/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9382317	Issue Dt:	07/05/2016	Application #:	14661938	Filing Dt:	03/18/2015
Publication #:	US20150191539	Pub Dt:	07/09/2015
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9539249	Issue Dt:	01/10/2017	Application #:	14707122	Filing Dt:	05/08/2015
Publication #:	US20150238478	Pub Dt:	08/27/2015
Title:	PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

Patent #:	10975138	Issue Dt:	04/13/2021	Application #:	14788250	Filing Dt:	06/30/2015
Publication #:	US20160122427	Pub Dt:	05/05/2016
Title:	CORRECTLY FOLDED ETANERCEPT COMPOSITION

Patent #:	10435464	Issue Dt:	10/08/2019	Application #:	14845440	Filing Dt:	09/04/2015
Title:	METHODS FOR MAKING RECOMBINANT PROTEINS

Patent #:	9724414	Issue Dt:	08/08/2017	Application #:	14879847	Filing Dt:	10/09/2015
Publication #:	US20160039926	Pub Dt:	02/11/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9808525	Issue Dt:	11/07/2017	Application #:	14879885	Filing Dt:	10/09/2015
Publication #:	US20160031982	Pub Dt:	02/04/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10555929	Issue Dt:	02/11/2020	Application #:	15062331	Filing Dt:	03/07/2016
Publication #:	US20160263098	Pub Dt:	09/15/2016
Title:	METHODS FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND/OR LIPODYSTROPHY

Patent #:	9943601	Issue Dt:	04/17/2018	Application #:	15078755	Filing Dt:	03/23/2016
Publication #:	US20160199489	Pub Dt:	07/14/2016
Title:	ETANERCEPT FORMULATIONS STABILIZED WITH COMBINATIONS OF SUGARS AND POLYOLS

Patent #:	9682145	Issue Dt:	06/20/2017	Application #:	15155832	Filing Dt:	05/16/2016
Publication #:	US20160256545	Pub Dt:	09/08/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9707293	Issue Dt:	07/18/2017	Application #:	15155925	Filing Dt:	05/16/2016
Publication #:	US20160256546	Pub Dt:	09/08/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9789185	Issue Dt:	10/17/2017	Application #:	15155982	Filing Dt:	05/16/2016
Publication #:	US20160256547	Pub Dt:	09/08/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9757454	Issue Dt:	09/12/2017	Application #:	15162140	Filing Dt:	05/23/2016
Publication #:	US20160263226	Pub Dt:	09/15/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9770507	Issue Dt:	09/26/2017	Application #:	15193345	Filing Dt:	06/27/2016
Publication #:	US20160304599	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9731008	Issue Dt:	08/15/2017	Application #:	15193387	Filing Dt:	06/27/2016
Publication #:	US20160304600	Pub Dt:	10/20/2016
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	9737600	Issue Dt:	08/22/2017	Application #:	15193415	Filing Dt:	06/27/2016
Publication #:	US20160304601	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9782480	Issue Dt:	10/10/2017	Application #:	15193454	Filing Dt:	06/27/2016
Publication #:	US20160303233	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9724415	Issue Dt:	08/08/2017	Application #:	15193486	Filing Dt:	06/27/2016
Publication #:	US20160303234	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9731009	Issue Dt:	08/15/2017	Application #:	15193523	Filing Dt:	06/27/2016
Publication #:	US20160303235	Pub Dt:	10/20/2016
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	9770510	Issue Dt:	09/26/2017	Application #:	15209484	Filing Dt:	07/13/2016
Publication #:	US20160317667	Pub Dt:	11/03/2016
Title:	Etanercept Formulations Stabilized with Xylitol

Patent #:	11583584	Issue Dt:	02/21/2023	Application #:	15337845	Filing Dt:	10/28/2016
Title:	STABLE ADALIMUMAB COMPOSITIONS AND METHODS OF THEIR USE

Patent #:	9861695	Issue Dt:	01/09/2018	Application #:	15360678	Filing Dt:	11/23/2016
Publication #:	US20170072054	Pub Dt:	03/16/2017
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	9867816	Issue Dt:	01/16/2018	Application #:	15402941	Filing Dt:	01/10/2017
Publication #:	US20170143687	Pub Dt:	05/25/2017
Title:	PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

Patent #:	11071782	Issue Dt:	07/27/2021	Application #:	15492999	Filing Dt:	04/20/2017
Publication #:	US20170304445	Pub Dt:	10/26/2017
Title:	METHOD OF FILLING A CONTAINER WITH NO HEADSPACE

Patent #:	NONE	Issue Dt:		Application #:	15620513	Filing Dt:	06/12/2017
Publication #:	US20170273969	Pub Dt:	09/28/2017
Title:	Antidiabetic Solid Pharmaceutical Compositions

Patent #:	10780163	Issue Dt:	09/22/2020	Application #:	15653228	Filing Dt:	07/18/2017
Publication #:	US20170312361	Pub Dt:	11/02/2017
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10786566	Issue Dt:	09/29/2020	Application #:	15677857	Filing Dt:	08/15/2017
Publication #:	US20180021433	Pub Dt:	01/25/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10213508	Issue Dt:	02/26/2019	Application #:	15716005	Filing Dt:	09/26/2017
Publication #:	US20180028668	Pub Dt:	02/01/2018
Title:	Etanercept Formulations Stabilized with Xylitol

Patent #:	11001627	Issue Dt:	05/11/2021	Application #:	15720291	Filing Dt:	09/29/2017
Publication #:	US20180037642	Pub Dt:	02/08/2018
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	10159732	Issue Dt:	12/25/2018	Application #:	15726165	Filing Dt:	10/05/2017
Publication #:	US20180043018	Pub Dt:	02/15/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10207000	Issue Dt:	02/19/2019	Application #:	15726195	Filing Dt:	10/05/2017
Publication #:	US20180055929	Pub Dt:	03/01/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10159733	Issue Dt:	12/25/2018	Application #:	15726215	Filing Dt:	10/05/2017
Publication #:	US20180043019	Pub Dt:	02/15/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10286071	Issue Dt:	05/14/2019	Application #:	15729243	Filing Dt:	10/10/2017
Publication #:	US20180028653	Pub Dt:	02/01/2018
Title:	Syringe Containing Stable Aqueous Formulations of Adalimumab

Patent #:	10286072	Issue Dt:	05/14/2019	Application #:	15729295	Filing Dt:	10/10/2017
Title:	METHODS OF MANUFACTURING STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	NONE	Issue Dt:		Application #:	15730399	Filing Dt:	10/11/2017
Publication #:	US20180028655	Pub Dt:	02/01/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	NONE	Issue Dt:		Application #:	15730425	Filing Dt:	10/11/2017
Publication #:	US20180028656	Pub Dt:	02/01/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	NONE	Issue Dt:		Application #:	15730445	Filing Dt:	10/11/2017
Publication #:	US20180028657	Pub Dt:	02/01/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	NONE	Issue Dt:		Application #:	15745365	Filing Dt:	01/16/2018
Publication #:	US20210322549	Pub Dt:	10/21/2021
Title:	Stable Aqueous Formulations of Natalizumab

Patent #:	NONE	Issue Dt:		Application #:	15793976	Filing Dt:	10/25/2017
Publication #:	US20180043020	Pub Dt:	02/15/2018
Title:	METHOD OF REDUCING IMMUNOGENICITY OF DRUG PRODUCTS

Patent #:	11135267	Issue Dt:	10/05/2021	Application #:	15799798	Filing Dt:	10/31/2017
Publication #:	US20180125982	Pub Dt:	05/10/2018
Title:	Etanercept Formulations Stabilized with Metal Ions

Patent #:	10155039	Issue Dt:	12/18/2018	Application #:	15799851	Filing Dt:	10/31/2017
Publication #:	US20180055930	Pub Dt:	03/01/2018
Title:	Stable Aqueous Formulations of Adalimumab

Patent #:	10195275	Issue Dt:	02/05/2019	Application #:	15866154	Filing Dt:	01/09/2018
Publication #:	US20180140701	Pub Dt:	05/24/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10376588	Issue Dt:	08/13/2019	Application #:	15917333	Filing Dt:	03/09/2018
Publication #:	US20180193463	Pub Dt:	07/12/2018
Title:	Etanercept Formulations Stabilized with Combinations of Sugars and Polyols

Patent #:	10772959	Issue Dt:	09/15/2020	Application #:	16023046	Filing Dt:	06/29/2018
Publication #:	US20180311349	Pub Dt:	11/01/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10772960	Issue Dt:	09/15/2020	Application #:	16023152	Filing Dt:	06/29/2018
Publication #:	US20180311350	Pub Dt:	11/01/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10799585	Issue Dt:	10/13/2020	Application #:	16023161	Filing Dt:	06/29/2018
Publication #:	US20180311351	Pub Dt:	11/01/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10688183	Issue Dt:	06/23/2020	Application #:	16023205	Filing Dt:	06/29/2018
Publication #:	US20180311352	Pub Dt:	11/01/2018
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	11001623	Issue Dt:	05/11/2021	Application #:	16102157	Filing Dt:	08/13/2018
Publication #:	US20180346550	Pub Dt:	12/06/2018
Title:	METHOD OF MANUFACTURING A PROTEIN BY PERFUSION IN MEDIA WITH A LOW AMINO ACID CONCENTRATION

Patent #:	10722579	Issue Dt:	07/28/2020	Application #:	16178137	Filing Dt:	11/01/2018
Publication #:	US20190060455	Pub Dt:	02/28/2019
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10716852	Issue Dt:	07/21/2020	Application #:	16178164	Filing Dt:	11/01/2018
Publication #:	US20190070292	Pub Dt:	03/07/2019
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10716853	Issue Dt:	07/21/2020	Application #:	16178309	Filing Dt:	11/01/2018
Publication #:	US20190070293	Pub Dt:	03/07/2019
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10716854	Issue Dt:	07/21/2020	Application #:	16178319	Filing Dt:	11/01/2018
Publication #:	US20190070294	Pub Dt:	03/07/2019
Title:	STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB

Patent #:	10772963	Issue Dt:	09/15/2020	Application #:	16284265	Filing Dt:	02/25/2019
Publication #:	US20190184017	Pub Dt:	06/20/2019
Title:	ETANERCEPT FORMULATIONS STABILIZED WITH XYLITOL

Patent #:	11667702	Issue Dt:	06/06/2023	Application #:	16297387	Filing Dt:	03/08/2019
Publication #:	US20190276528	Pub Dt:	09/12/2019
Title:	Stable Aqueous Formulations of Aflibercept

Patent #:	NONE	Issue Dt:		Application #:	16326018	Filing Dt:	02/15/2019
Publication #:	US20210379049	Pub Dt:	12/09/2021
Title:	PPAR-gamma AGONIST FOR TREATMENT OF BLOOD CANCERS

Patent #:	NONE	Issue Dt:		Application #:	16326070	Filing Dt:	02/15/2019
Publication #:	US20190167660	Pub Dt:	06/06/2019
Title:	PPAR-gamma AGONIST FOR TREATMENT OF BONE DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	16333171	Filing Dt:	03/13/2019
Publication #:	US20190224186	Pub Dt:	07/25/2019
Title:	TREATMENT OF MULTIPLE SCLEROSIS WITH CHS-131

Patent #:	11129876	Issue Dt:	09/28/2021	Application #:	16360196	Filing Dt:	03/21/2019
Publication #:	US20190216930	Pub Dt:	07/18/2019
Title:	ETANERCEPT FORMULATIONS STABILIZED WITH AMINO ACIDS

Patent #:	NONE	Issue Dt:		Application #:	16371652	Filing Dt:	04/01/2019
Publication #:	US20190298708	Pub Dt:	10/03/2019
Title:	METHODS OF TREATING SUBJECTS WITH AN ELEVATED NEUROFILAMENT LIGHT CHAIN LEVEL

Patent #:	10980884	Issue Dt:	04/20/2021	Application #:	16441092	Filing Dt:	06/14/2019
Publication #:	US20190290766	Pub Dt:	09/26/2019
Title:	Stable Aqueous Etanercept Composition

Patent #:	10980885	Issue Dt:	04/20/2021	Application #:	16441095	Filing Dt:	06/14/2019
Publication #:	US20190290767	Pub Dt:	09/26/2019
Title:	Method of Reducing Formation of Etanercept Aggregates or Fragments

Patent #:	10888619	Issue Dt:	01/12/2021	Application #:	16441103	Filing Dt:	06/14/2019
Publication #:	US20190290768	Pub Dt:	09/26/2019
Title:	Stable Aqueous Etanercept Composition

Patent #:	10987405	Issue Dt:	04/27/2021	Application #:	16441110	Filing Dt:	06/14/2019
Publication #:	US20190298837	Pub Dt:	10/03/2019
Title:	Method of Reducing Formation of Etanercept Aggregates or Fragments

Patent #:	10954293	Issue Dt:	03/23/2021	Application #:	16443514	Filing Dt:	06/17/2019
Publication #:	US20190300600	Pub Dt:	10/03/2019
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	10954294	Issue Dt:	03/23/2021	Application #:	16443594	Filing Dt:	06/17/2019
Publication #:	US20190300601	Pub Dt:	10/03/2019
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	10947306	Issue Dt:	03/16/2021	Application #:	16443688	Filing Dt:	06/17/2019
Publication #:	US20190330325	Pub Dt:	10/31/2019
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	10954295	Issue Dt:	03/23/2021	Application #:	16443721	Filing Dt:	06/17/2019
Publication #:	US20190300602	Pub Dt:	10/03/2019
Title:	CORRECTLY FOLDED ETANERCEPT IN HIGH PURITY AND EXCELLENT YIELD

Patent #:	11000588	Issue Dt:	05/11/2021	Application #:	16456267	Filing Dt:	06/28/2019
Publication #:	US20190343955	Pub Dt:	11/14/2019
Title:	Etanercept Formulations Stabilized with Sodium Chloride

Patent #:	NONE	Issue Dt:		Application #:	16476979	Filing Dt:	07/10/2019
Publication #:	US20190350918	Pub Dt:	11/21/2019
Title:	PPARy AGONIST FOR TREATMENT OF HUNTINGTON'S DISEASE

Patent #:	11396540	Issue Dt:	07/26/2022	Application #:	16564642	Filing Dt:	09/09/2019
Title:	METHODS FOR MAKING RECOMBINANT PROTEINS

Patent #:	11426446	Issue Dt:	08/30/2022	Application #:	16566847	Filing Dt:	09/10/2019
Publication #:	US20200246423	Pub Dt:	08/06/2020
Title:	STABLE AQUEOUS FORMULATIONS OF AFLIBERCEPT

Patent #:	NONE	Issue Dt:		Application #:	16704776	Filing Dt:	12/05/2019
Publication #:	US20200207812	Pub Dt:	07/02/2020
Title:	METHODS FOR PRODUCING RECOMBINANT PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	16728523	Filing Dt:	12/27/2019
Publication #:	US20200207823	Pub Dt:	07/02/2020
Title:	PROCESS FOR PRODUCING, ISOLATING, AND PURIFYING MODIFIED RECOMBINANT PROTEINS

Patent #:	10772865	Issue Dt:	09/15/2020	Application #:	16744433	Filing Dt:	01/16/2020
Publication #:	US20200147036	Pub Dt:	05/14/2020
Title:	METHODS FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND/OR LIPODYSTROPHY

Patent #:	11400072	Issue Dt:	08/02/2022	Application #:	16911721	Filing Dt:	06/25/2020
Publication #:	US20200383945	Pub Dt:	12/10/2020
Title:	METHODS FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND/OR LIPODYSTROPHY

Patent #:	NONE	Issue Dt:		Application #:	17019722	Filing Dt:	09/14/2020
Publication #:	US20200405865	Pub Dt:	12/31/2020
Title:	ETANERCEPT FORMULATIONS STABILIZED WITH XYLITOL

Patent #:	NONE	Issue Dt:		Application #:	17034134	Filing Dt:	09/28/2020
Publication #:	US20210007991	Pub Dt:	01/14/2021
Title:	ETANERCEPT FORMULATIONS EXHIBITING MARKED REDUCTION IN SUB-VISIBLE PARTICLES

Patent #:	11576971	Issue Dt:	02/14/2023	Application #:	17350299	Filing Dt:	06/17/2021
Publication #:	US20220040300	Pub Dt:	02/10/2022
Title:	METHOD OF FILLING A CONTAINER WITH NO HEADSPACE

Patent #:	NONE	Issue Dt:		Application #:	17419559	Filing Dt:	06/29/2021
Publication #:	US20220143003	Pub Dt:	05/12/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17600168	Filing Dt:	09/30/2021
Publication #:	US20220193102	Pub Dt:	06/23/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17600172	Filing Dt:	09/30/2021
Publication #:	US20220193065	Pub Dt:	06/23/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17600178	Filing Dt:	09/30/2021
Publication #:	US20220288053	Pub Dt:	09/15/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17600194	Filing Dt:	09/30/2021
Publication #:	US20220175758	Pub Dt:	06/09/2022
Title:	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

Patent #:	NONE	Issue Dt:		Application #:	17608204	Filing Dt:	11/02/2021
Publication #:	US20220195029	Pub Dt:	06/23/2022
Title:	METHOD OF PRODUCING A RECOMBINANT PROTEIN

100

Patent #:	NONE	Issue Dt:		Application #:	17613012	Filing Dt:	11/19/2021
Publication #:	US20220202804	Pub Dt:	06/30/2022
Title:	COMPOSITIONS AND METHODS TO TREAT CANCER

Assignors

COHERUS BIOSCIENCES, INC.

Exec Dt:

01/05/2022

COHERUS INTERMEDIATE CORP.

Exec Dt:

01/05/2022

INTEKRIN THERAPEUTICS INC.

Exec Dt:

01/05/2022

Assignee

BIOPHARMA CREDIT PLC

C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD

EXETER EX4 4EP, UNITED KINGDOM

Correspondence name and address
	MUSSIE B BEYENE
	2001 K STREET N.W.
	WASHINGTON DC, DC 20006

Search Results as of: 05/29/2024 01:42 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6